Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Zirdu who wrote (4995)	7/25/1998 11:56:00 AM
From: billkirn	Respond to of 6136

RRanney: That is really significant. My guess is that we at the beginning of a sea change. The overall market may slow our progress but things are changing for Agouron and in the right direction. Bill

To: Zirdu who wrote (4995)	7/25/1998 12:28:00 PM
From: Steve Fancy	Respond to of 6136

RR, that is interesting. Thanks. - sf <eom>

To: Zirdu who wrote (4995)	7/26/1998 6:47:00 PM
From: mumbles	Read Replies (1) \| Respond to of 6136

This is a pretty basic question but I have not seen it discussed on this thread: What are the implications of the new stock for current short sellers? If there still short on the effective date, won't they have to replace the new stock that existing holders will be entitled to like any other dividend? Could this lead to a rethinking of the short case? Would be interested to know what has happened in other cases. mumbles